China In-vitro Diagnostic (IVD) Market By Test Location (Point of Care, Home Care), By Product (Instruments, Services) Size and Forecast
Report ID: 469730|No. of Pages: 202
China In-vitro Diagnostic (IVD) Market By Test Location (Point of Care, Home Care), By Product (Instruments, Services) Size and Forecast
China In-vitro Diagnostic (IVD) Market Size and Forecast
The China In-vitro Diagnostic (IVD) Market was valued at USD 12.60 Billion in 2024 and is projected to reach USD 24.79 Billion by 2031, growing at a CAGR of 9.2% from 2024 to 2031.
- The China IVD market includes a wide range of diagnostic tests and devices used for detecting diseases, monitoring health conditions, and guiding medical treatment. This encompasses products such as reagents, diagnostic instruments, molecular diagnostic tests, immunoassays, and point-of-care testing devices.
- These diagnostic instruments are essential for customized treatment, early disease identification, and prevention, which enhances patient outcomes and lowers medical expenses. The aging population, the rising incidence of chronic diseases (such as diabetes, cancer, and cardiovascular diseases), and the need for quicker, more accurate, and more efficient diagnostic methods are all contributing to the market’s explosive growth.
- Additionally, the development of PCR-based testing, AI-driven diagnostic solutions, and molecular diagnostics is helping the market. The use of IVD products in clinics, hospitals, and home care settings is being fuelled by the increased emphasis on early illness identification and preventative healthcare.
- Looking ahead, the future outlook for China’s IVD market is strong, supported by increasing government healthcare investments, the adoption of digital health technologies, and the continued emphasis on expanding access to healthcare. Additionally, local and international collaborations, as well as innovation in diagnostic platforms, are expected to contribute to the market’s growth in the coming years.
China In-vitro Diagnostic (IVD) Market Dynamics
The key market dynamics that are shaping the China in-vitro diagnostic (IVD) market include:
Key Market Drivers:
- Growing Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases is one of the primary drivers for the China IVD market. According to the World Health Organization (WHO), China has the largest number of diabetes patients in the world, with over 140 million individuals affected by the disease. In-vitro diagnostic (IVD) products are useful because of the increasing prevalence of chronic diseases, which necessitates ongoing monitoring and early detection. According to National Library of Medicine, it was estimated about 4,824,700 new cancer cases and 2,574,200 new cancer deaths occurred in China in 2022. As a result, demand for diagnostic tools such as molecular tests, biomarkers, and imaging solutions is expected to continue growing rapidly.
- Aging Population: China’s rapidly aging population is also contributing significantly to the expansion of the IVD market. According to World Health Organization, China has one of the fastest growing ageing populations in the world. The population of people over 60 years old in China is projected to reach 28% by 2040. As the elderly population increases, so does the incidence of age-related conditions like heart disease, stroke, dementia, and neurodegenerative diseases, all of which require regular diagnostics. This demographic shift is creating a strong demand for IVD solutions such as point-of-care testing devices, immunoassays, and molecular diagnostics, particularly for the early detection of age-related diseases.
- Government Support and Healthcare Reforms: The Chinese government’s ongoing investments in healthcare infrastructure and the Healthy China 2030 initiative are major drivers of growth for the IVD market. The China Food and Drug Administration (CFDA) has been actively working to improve diagnostic regulatory procedures and encourage the clearance of novel IVD technology. Further propelling the market’s expansion are government-supported programs like the National Medical Products Administration (NMPA) and the drive for universal healthcare access, which are encouraging the use of IVD products in both urban and rural areas.
- Technological Advancements and Innovation: Technological advancements in diagnostic testing, particularly in molecular diagnostics, genomic testing, and point-of-care (POC) devices, are significantly propelling the IVD market in China. The use of advanced technologies such as PCR, next-generation sequencing (NGS), and CRISPR-based diagnostic tools is revolutionizing disease detection, enabling earlier and more accurate results. These innovations are enhancing diagnostic accuracy and accessibility, making IVD products an essential part of China’s modern healthcare landscape.
Key Challenges
- Regulatory Approval Delays: One of the key challenges in the China IVD market is the lengthy regulatory approval process. According to the China National Medical Products Administration (NMPA), new IVD products can take up to 12-24 months for approval. Delays in regulatory processes can slow down the market entry of innovative products, hindering manufacturers from capitalizing on market opportunities in a timely manner.
- Intense Domestic Competition: China’s IVD market is highly competitive, with local players like Wondfo Biotech and Mindray accounting for over 60% of the market share in 2023. Local producers may provide goods at lower costs, putting a lot of pressure on international businesses to lower their prices. International businesses find it difficult to hold onto their market share due to the competition and a concentration on price-sensitive markets like point-of-care diagnostics.
- Inconsistent Access to Healthcare: Access to advanced diagnostic tools varies greatly across China, especially between urban and rural regions. This uneven distribution limits the reach of IVD technologies in underdeveloped areas, restricting the overall market potential.
Key Trends
- Growth in Molecular Diagnostics: Molecular diagnostics are rapidly gaining traction in China due to their ability to provide faster and more accurate disease detection. Key players like Roche Diagnostics and Abbott Laboratories are expanding their molecular test portfolios to address the rising prevalence of diseases like cancer and infectious diseases.
- Shift Toward Point-of-Care Testing: There is a growing trend toward point-of-care (POC) testing solutions in China, driven by the need for quicker, more accessible diagnostics. Companies like Siemens Healthineers and Wondfo Biotech are investing in easy-to-use, rapid testing devices that can be used in remote or low-resource settings, offering greater convenience and accessibility.
- Government Push for Healthcare Innovation: The Chinese government’s Healthy China 2030 initiative is driving the adoption of innovative IVD solutions, with an emphasis on healthcare modernization and early disease detection. The Chinese government has invested 1920.1 billion yuan on healthcare in 2020, focusing on technological advancements and the wider adoption of diagnostic tools. This policy is encouraging both local and international companies to increase their investment in IVD products tailored to China’s growing healthcare needs.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=469730
China In-vitro Diagnostic (IVD) Market Regional Analysis
Here is a more detailed regional analysis of the China in-vitro diagnostic (IVD) market:
- Beijing and Shanghai dominate China’s IVD market due to their robust healthcare infrastructure and high concentration of leading medical research institutions and hospitals. These cities have been key players in the adoption of advanced diagnostic technologies, including molecular diagnostics, genetic testing, and immunoassays. The Shanghai Health Commission also highlighted increased demand for precision medicine and AI-driven diagnostics, driving the market in these metropolitan regions.
- Chengdu and Guangzhou are emerging as some of the fastest-growing markets for IVD in China, fuelled by rising healthcare investments and expanding medical networks. With a fast-expanding healthcare industry, Chengdu is seeing significant growth in diagnostic technology, especially in fields like molecular diagnostics and point-of-care testing. Due to investments in new clinics and hospitals, the city’s healthcare spending is expected to increase by 12–15% a year. Similar to this, Guangzhou is emerging as a major centre for IVD innovation owing to partnerships between local government agencies and businesses like Wondfo Biotech that increase the accessibility of diagnostic tools.
China In-vitro Diagnostic (IVD) Market: Segmentation Analysis
The China In-vitro Diagnostic (IVD) Market is segmented on the basis of Test Location, Product.
China In-vitro Diagnostic (IVD) Market, By Test Location
- Point of Care
- Home Care
Based on Test Location, the China In-vitro Diagnostic (IVD) Market is segmented into Point of Care, Home Care. The Point of Care (POC) testing segment dominates the China IVD market due to its growing demand for rapid and convenient diagnostic solutions in both healthcare facilities and remote settings. POC tests, which provide immediate results, are becoming increasingly popular in hospitals, clinics, and emergency care centres. The Home Care segment of the China IVD market is expanding rapidly as patients increasingly prefer self-testing and at-home diagnostics. Home testing kits for conditions like diabetes, pregnancy, ovulation, and COVID-19 have seen significant uptake in recent years.
China In-vitro Diagnostic (IVD) Market, By Product
- Instruments
- Services
Based on the Product, the China In-vitro Diagnostic (IVD) Market is segmented into Instruments, Services. The Instruments segment dominates the China IVD market, driven by advancements in diagnostic technology and increasing demand for precision testing. Diagnostic instruments, including analysers, automated systems, and molecular diagnostic devices, are essential for both clinical laboratories and point-of-care testing settings. The growing emphasis on early disease detection, particularly for cancer, diabetes, and infectious diseases, is fuelling the expansion of this segment. The Services segment of the China IVD market is also witnessing rapid growth, driven by the increasing demand for laboratory testing services, molecular diagnostics, and genetic testing.
Key Players
The “China In-vitro Diagnostic (IVD) Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Mindray Medical International, Wondfo Biotech.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
China In-vitro Diagnostic (IVD) Market: Recent Developments
- In April 2023, Roche Diagnostics launched an advanced PCR testing system aimed at improving early disease detection and pandemic response capabilities in China. This new system enhances the speed and accuracy of infectious disease testing, particularly for COVID-19, influenza, and tuberculosis.
- In June 2023, Mindray introduced a new range of molecular diagnostic platforms designed to streamline the detection of genetic disorders and infectious diseases. The platforms are equipped with AI-powered analytics to provide faster results, contributing to the company’s growth in the rapidly expanding molecular diagnostics segment.
- In August 2023, Abbott Laboratories launched a new at-home diagnostic kit for cardiac biomarkers, enabling patients to monitor their health remotely. This launch targets the rising demand for home care diagnostics in China, where consumers are increasingly seeking self-testing solutions for chronic conditions.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| STUDY PERIOD | 2021-2031 |
| BASE YEAR | 2024 |
| FORECAST PERIOD | 2024-2031 |
| HISTORICAL PERIOD | 2021-2023 |
| UNIT | Value (USD Billion) |
| KEY COMPANIES PROFILED | Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Mindray Medical International, Wondfo Biotech. |
| SEGMENTS COVERED |
|
| CUSTOMIZATION SCOPE | Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1. Introduction
• Market Definition
• Market Segmentation
• Research Methodology
2. Executive Summary
• Key Findings
• Market Overview
• Market Highlights
3. Market Overview
• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter’s Five Forces Analysis
4. China In-vitro Diagnostic (IVD) Market, By Test Location
• Point of Care
• Home Care
5. China In-vitro Diagnostic (IVD) Market, By Product
• Instruments
• Services
6. Regional Analysis
• China
7. Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market
8. Competitive Landscape
• Key Players
• Market Share Analysis
9. Company Profiles
• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Mindray Medical International
• Wondfo Biotech
10. Market Outlook and Opportunities
• Emerging Technologies
• Future Market Trends
• Investment Opportunities
11. Appendix
• List of Abbreviations
• Sources and References
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
